3R2X image
Deposition Date 2011-03-14
Release Date 2011-05-11
Last Version Date 2024-11-27
Entry Detail
PDB ID:
3R2X
Title:
Crystal structure of the de novo designed binding protein HB36.3 in complex the the 1918 influenza virus hemagglutinin
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.10 Å
R-Value Free:
0.24
R-Value Work:
0.22
R-Value Observed:
0.22
Space Group:
H 3 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Hemagglutinin
Gene (Uniprot):HA
Chain IDs:A
Chain Length:331
Number of Molecules:1
Biological Source:Influenza A virus
Polymer Type:polypeptide(L)
Molecule:Hemagglutinin
Gene (Uniprot):HA
Chain IDs:B
Chain Length:179
Number of Molecules:1
Biological Source:Influenza A virus
Polymer Type:polypeptide(L)
Molecule:HB36.3, designed hemagglutinin binding protein
Chain IDs:C
Chain Length:93
Number of Molecules:1
Biological Source:artificial gene
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN A ASN GLYCOSYLATION SITE
Ligand Molecules
Primary Citation
Computational design of proteins targeting the conserved stem region of influenza hemagglutinin.
Science 332 816 821 (2011)
PMID: 21566186 DOI: 10.1126/science.1202617

Abstact

We describe a general computational method for designing proteins that bind a surface patch of interest on a target macromolecule. Favorable interactions between disembodied amino acid residues and the target surface are identified and used to anchor de novo designed interfaces. The method was used to design proteins that bind a conserved surface patch on the stem of the influenza hemagglutinin (HA) from the 1918 H1N1 pandemic virus. After affinity maturation, two of the designed proteins, HB36 and HB80, bind H1 and H5 HAs with low nanomolar affinity. Further, HB80 inhibits the HA fusogenic conformational changes induced at low pH. The crystal structure of HB36 in complex with 1918/H1 HA revealed that the actual binding interface is nearly identical to that in the computational design model. Such designed binding proteins may be useful for both diagnostics and therapeutics.

Legend

Protein

Chemical

Disease

Primary Citation of related structures